当前位置:首页 - 行情中心 - 诚达药业(301201) - 财务分析 - 现金流量表

诚达药业

(301201)

  

流通市值:38.38亿  总市值:54.71亿
流通股本:1.09亿   总股本:1.55亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金266,408,693.25107,366,146.78470,723,644.57337,456,785.95
  收到的税费返还578,486.11279,315.46-2,710,909.41
  收到其他与经营活动有关的现金19,739,522.578,846,033.7359,781,641.419,971,655.7
  经营活动现金流入小计286,726,701.93116,491,495.97530,505,285.97360,139,351.06
  购买商品、接受劳务支付的现金151,955,420.2280,205,663.54284,784,688.72178,074,991.1
  支付给职工以及为职工支付的现金53,500,083.9626,681,027.3894,357,271.1971,171,518.67
  支付的各项税费10,554,777.926,595,363.664,651,007.335,985,608.26
  支付其他与经营活动有关的现金27,482,841.0914,421,949.53112,694,571.3138,445,335.11
  经营活动现金流出小计243,493,123.19127,904,004.11496,487,538.55293,677,453.14
  经营活动产生的现金流量净额43,233,578.74-11,412,508.1434,017,747.4266,461,897.92
二、投资活动产生的现金流量:
  收回投资收到的现金1,884,000,136.19884,000,0008,245,048,197.055,829,968,276.27
  取得投资收益收到的现金4,113,518.411,799,459.1918,147,672.5317,353,463.56
  处置固定资产、无形资产和其他长期资产收回的现金净额135,328135,3281,222,770.64256,717
  投资活动现金流入小计1,888,248,982.6885,934,787.198,264,418,640.225,847,578,456.83
  购建固定资产、无形资产和其他长期资产支付的现金52,119,841.7824,048,516.7769,019,320.84110,558,933.01
  投资支付的现金2,064,000,000844,000,0007,929,000,002.235,124,000,000
  投资活动现金流出小计2,116,119,841.78868,048,516.777,998,019,323.075,234,558,933.01
  投资活动产生的现金流量净额-227,870,859.1817,886,270.42266,399,317.15613,019,523.82
三、筹资活动产生的现金流量:
  取得借款收到的现金0-8,951,765.598,079,300
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计0-8,951,765.598,079,300
  偿还债务支付的现金7,388,718.224,95030,000,00030,000,000
  分配股利、利润或偿付利息支付的现金784,558.08399,125.3732,821,485.2830,921,641.61
  筹资活动现金流出小计8,173,276.3404,075.3762,821,485.2860,921,641.61
  筹资活动产生的现金流量净额-8,173,276.3-404,075.37-53,869,719.69-52,842,341.61
四、汇率变动对现金及现金等价物的影响-1,650,501.55-773,506.1776,311.8641,316.71
五、现金及现金等价物净增加额-194,461,058.295,296,180.81247,323,656.68627,280,396.84
  加:期初现金及现金等价物余额424,264,827.58424,264,827.58176,941,170.9176,941,170.9
  期末现金及现金等价物余额229,803,769.29429,561,008.39424,264,827.58804,221,567.74
补充资料:
  净利润2,292,610.28--11,961,222.21-
  资产减值准备1,854,009.35-35,566,178.42-
  固定资产和投资性房地产折旧36,658,248.23-71,130,418.9-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧36,658,248.23-71,130,418.9-
  无形资产摊销994,709.94-1,832,260.09-
  长期待摊费用摊销8,688,645.36-18,059,299.8-
  处置固定资产、无形资产和其他长期资产的损失52,477.88--37,332.75-
  固定资产报废损失1,123,601.19-5,746,454.83-
  公允价值变动损失-6,177,968.26--2,849,373.74-
  财务费用3,291,675.05-1,505,103.08-
  投资损失1,005,813.44--12,343,763.11-
  递延所得税-539,940.08--4,694,010.2-
  其中:递延所得税资产减少-1,212,750.4--4,162,210.96-
    递延所得税负债增加672,810.32--531,799.24-
  存货的减少-18,599,861.72--39,582,455.85-
  经营性应收项目的减少-7,917,205.46--22,505,527.48-
  经营性应付项目的增加1,482,123.32--5,848,282.36-
  其他19,024,640.22---
  现金的期末余额229,803,769.29-424,264,827.58-
  减:现金的期初余额424,264,827.58-176,941,170.9-
  现金及现金等价物的净增加额-194,461,058.29-247,323,656.68-
公告日期2026-08-262026-04-282026-04-282025-10-28
审计意见(境内)标准无保留意见
TOP↑